Abstract
Behçet's disease is an inflammatory vasculitic disease of unknown etiology characterized by recurrent oral and genital ulcers, ocular findings, and multiple organ involvement. Mucocutaneous findings are the most common symptoms. The most used diagnostic criteria are International Criteria for BD (ICBD), International Study Group (ISG) criteria and pediatric Behçet’s disease criteria (PEDBD). Although diagnostic criteria have been defined, the diagnosis is still difficult due to clinical findings developed in pediatric patients. The aim of this study was to evaluate the clinical findings, phenotype characteristics, sensitivity and specificity of diagnostic criteria, and the course of pediatric Behçet's disease (BD). We evaluated retrospectively the files of 67 (29 M/38 F) patients diagnosed with BD according to expert opinion. The patients were reclassified according to ISG, ICBD, and PEDBD criteria. The control group consisted of a total of 69 patients with BD-mimicking diseases or presenting at least one major BD sign followed at the same center. Sensitivity and specificity were evaluated for the criteria. The mean age of diagnosis was 13.38 ± 3.2 years. There were oral aphthous ulcers in 98.5%, genital ulcers in 68.7%, skin lesions in 31.3%, vascular involvement in 17.9%, neurological involvement in 11.9%, positive pathergy test in 33.8%, and positive HLA-B51 in 57.1% of patients. The sensitivity of ICBD, ISG and PEDBD criteria was 88.1, 43.3, and 37.3%, respectively. The specificity of ICBD, ISG, and PEDBD criteria was 100%. Diagnosis of BD in childhood is still difficult. ICBD criteria have the highest sensitivity among the diagnostic criteria. These criteria can also be used in childhood.
Similar content being viewed by others
References
Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V (2019) One year in review 2019: Behçet’s syndrome. Clin Exp Rheumatol 37(Suppl 121):3–17
Shahram F, Nadji A, Akhlaghi M, Faezi ST, Chams-Davatchi C, Shams H et al (2018) Pediatric Behçet’s disease in Iran: report of 204 cases. Clin Exp Rheumatol 36(6 Suppl 115):135–140
Ishido T, Horita N, Takeuchi M, Kawagoe T, Shibuya E, Yamane T et al (2017) Clinical manifestations of Behçet’s disease depending on sex and age: results from Japanese nationwide registration. Rheumatology (Oxford) 56(11):1918–1927
Karincaoglu Y, Borlu M, Toker SC, Akman A, Onder M, Gunastı S et al (2008) Demographic and clinical properties of juvenile-onset Behçet’s disease: a controlled multicenter study. J Am Acad Dermatol 58(4):579–584
Rodríguez-Carballeira M, Solans R, Larrañaga JR, García-Hernández FJ, Rios-Fernández R, Nieto J et al (2018) Venous thrombosis, and relapses in patients with Behçet’s disease. Descriptive analysis from Spanish network of Behçet’s disease (REGEB cohort). Clin Exp Rheumatol. 36(6 Suppl):40–44
Maldini C et al (2018) Exploring the variability in Behcet’s disease prevalence: a metaanalytical approach. Rheumatology (Oxford) 57(1):185–195
Poddighe D, Turganbekova A, Mukusheva Z, Abdirakhmanova A, Assylbekova M, Abdrakhmanova S (2020) HLA-B*51 allelic and carrier frequency in Kazakhstan: insights into Behçet’s disease prevalence in Central Asia. Intern Emerg Med. https://doi.org/10.1007/s11739-020-02369-1
Akkoç N (2018) Update on the epidemiology, risk factors and disease outcomes of Behçet’s disease. Best Pract Res Clin Rheumatol 32(2):261–270
Davatchi F, Sadeghi Abdollahi B, Chams-Davatchi C, Shahram F, Shams H, Nadji A et al (2015) The saga of diagnostic/classification criteria in Behcet’s disease. Int J Rheum Dis 18(6):594–605
Criteria for diagnosis of Behçet’s disease (1990) International Study Group for Behçet’s disease. Lancet 335(8697):1078–1080
International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD) (2014) The International Criteria for Behçet’s Disease ICBD: a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28(3):338–347
Kone-Paut I et al (2016) Consensus classification criteria for pediatric Behcet’s disease from a prospective observational cohort: PEDBD. Ann Rheum Dis 75(6):958–964
Krause I, Uziel Y, Guedj D et al (1999) Childhood Behcet’s disease: clinical features and comparison with adult-onset disease. Rheumatology 38(5):457–462
Batu ED, Sönmez HE, Sözeri B, Butbul Aviel Y, Bilginer Y, Özen S (2017) The performance of different classification criteria in pediatric Behcet’s disease. Clin Exp Rheumatol 35(Suppl 108):119–123
Gallizzi R et al (2017) A national cohort study on pediatric Behcet’s disease: cross sectional data from an Italian registry. Pediatr Rheumatol Online J 15(1):84
Maldini C, Lavalley MP, Cheminant M, de Menthon M, Mahr A (2012) Relationships of HLA-B51 or B5 genotype with Behcet’s disease clinical characteristics: systematic review and meta-analyses of observational studies. Rheumatology (Oxford) 51(5):887–900
Ambrose NL, Haskard DO (2013) Differential diagnosis and management of Behçet syndrome. Nat Rev Rheumatol 9(2):79–89
Kang EH, Kim JY, Takeuchi F, Kim JW, Shin K, Lee EY et al (2011) Associations between the HLA-A polymorphism and the clinical manifestations of Behcet’s disease. Arthritis Res Ther 13(2):R49
Funding
The research did not receive funding.
Author information
Authors and Affiliations
Contributions
TK, MD Organization of the paper and substantial contribution to the acquisition of data. FA, NT, MS, ZET, EC, CK, SC, BA, MD Organization of the paper and revision critically for intellectual content.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to declare.
Ethical approval
Ethics committee approval was received for this study, from the scientific and ethics committee of our hospital (approval number: E1/891/20202; approval date: February 7, 2020).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kurt, T., Aydın, F., Sezer, M. et al. Performance of diagnostic criteria in pediatric Behçet’s disease. Rheumatol Int 42, 127–132 (2022). https://doi.org/10.1007/s00296-020-04777-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-020-04777-0